Shanghai, China · Founded 2021 · Privately Held (backing)
Operator of a clinical-stage biopharmaceutical company intended to focus on the discovery, development, and commercialization of novel targeted radiopharmaceuticals to address significant unmet… Biovision Biomedical Technology is based in Shanghai, China and was founded in 2021. It has raised $42.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$42.3M
Last round
—
How much has Biovision Biomedical Technology raised?
$42.3Macross 0 recorded rounds
Free account
More of Biovision Biomedical Technology with a free account
·Watch Biovision Biomedical Technology: the Monday email on marks, rounds and moves